2026 Critical Care Congress Skip to main content
2026 Critical Care Congress Main banner
Final Program


Advance Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Thought Leader Session
Thought Leader Session
Guidelines Session
Guidelines Session
Aging Adult Track
Aging Adult Track
Additional Registration Fee
Additional Registration Fee

Ethics End of Life

Pro/Con: Should Cost Containment Impact Bedside Decision-Making?

Con: The Clinical Team Should Not Be Involved in Cost Containment

Sunday, March 22, 2026
10:35 AM - 10:55 AM Central Time

  • John A. Kellum, MD, MCCM

    University of Pittsburgh School of Medicine, Pennsylvania

    Disclosure(s): AstraZeneca: Consultant (Ongoing); Bayer: Consultant (Ongoing); Chugai Pharma: Consultant (Ongoing); Mitsubishi Tenabe,: Consultant (Ongoing); Spectral Medical: Board Member/Officer/Trustee (Ongoing), Employee (any industry) (Ongoing), Major Stockholder (not including mutual funds) (Ongoing), Salary (Ongoing)